Esta semana destacamos una publicación interesante de los Dres. Kiyoshi Egawa y Miho Watanabe de la Facultad de Medicina de la Universidad de Hokkaido y la
Para continuar con nuestro esfuerzo por desentrañar la jerga fuertemente científica y, a veces, desalentadora que se usa en toda la comunidad del síndrome
Summary by Allyson Berent, DVM, DACVIM Individuals affected with Angelman syndrome (AS) are known to have limited functional speech and are typically able to
“Of all the childhood genetic neurologic disorders of the brain, Angelman syndrome may be the single best candidate for developing a definitive treatment (
Edwin Weeber, Ph.D. is a Professor in the Department of Molecular Pharmacology and Physiology and the Chief Scientific Officer at the University of South Flo
Stakeholders meet to develop Biomarkers and Outcome Measures for clinical trials in Angelman Syndrome We are thrilled to announce that the Angelman Syndrome
Read about the recently published paper «Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome
On May 11th in Castle Rock, Colorado, approximately 400 participants came out for the first-ever “Moms Rock 5K” for FAST! A virtual run was also held w
Did you know that the Angelman community is the driving force behind research into treatments and a cure for Angelman Syndrome? Did you know that the Angel
In March of 2013, the Tampa 24, wrapped up their final visits to Tampa General Hospital for the human clinical trial to test the efficacy of minocycline in t
